Compounds > levodopa
Page last updated: 2024-08-17

levodopa and olanzapine

levodopa has been researched along with olanzapine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's6 (54.55)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Ghaemi, M; Rudolf, J; Schmülling, S1
Factor, SA; Molho, ES1
Minagar, A; Shulman, LM; Weiner, WJ1
Lees, AJ; Manson, AJ; Schrag, A1
Alvarez, M; Chacón, JR; Durán, E; Durán, JA1
Gupta, N; Malhotra, P1
Bai, O; Bowen, R; Chlan-Fourney, J; Keegan, D; Li, XM1
Hoefnagels, WH; Horstink, MW; Scheepmaker, AJ; Strijks, FE1
Kanaya, Y; Kono, R; Kuriyama, M; Shiga, Y; Shimoe, Y; Takeshima, S1

Trials

2 trial(s) available for levodopa and olanzapine

ArticleYear
Low-dose olanzapine for levodopa induced dyskinesias.
    Neurology, 2000, Sep-26, Volume: 55, Issue:6

    Topics: Aged; Benzodiazepines; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Olanzapine; Pirenzepine

2000
[Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease].
    Neurologia (Barcelona, Spain), 2002, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Female; Humans; Levodopa; Male; Middle Aged; Olanzapine; Parkinson Disease; Pirenzepine; Prospective Studies; Psychoses, Substance-Induced

2002

Other Studies

9 other study(ies) available for levodopa and olanzapine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.
    European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:6

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Olanzapine; Paranoid Disorders; Parkinson Disease; Piperidines; Pirenzepine; Selegiline; Severity of Illness Index

1999
Worsening of motor features of parkinsonism with olanzapine.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:6

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Olanzapine; Parkinson Disease; Parkinson Disease, Secondary; Pirenzepine; Psychoses, Substance-Induced; Risk Factors

1999
Quetiapine for l-dopa-induced psychosis in PD.
    Neurology, 2000, Apr-11, Volume: 54, Issue:7

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Levodopa; Male; Olanzapine; Parkinson Disease; Pirenzepine; Psychoses, Substance-Induced; Quetiapine Fumarate; Treatment Outcome

2000
Olanzapine: a proarrhythmic drug?
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:7

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbidopa; Electrocardiography; Female; Humans; Levodopa; Long QT Syndrome; Olanzapine; Pirenzepine; Psychoses, Substance-Induced; Risk Factors

2002
Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs.
    Journal of neuroscience research, 2003, Jan-01, Volume: 71, Issue:1

    Topics: Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Clozapine; Dopamine Agents; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Hippocampus; In Situ Hybridization; Levodopa; Male; Olanzapine; Pirenzepine; Rats; Rats, Wistar; RNA, Messenger

2003
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Nederlands tijdschrift voor geneeskunde, 2003, Jan-04, Volume: 147, Issue:1

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbamates; Cholinesterase Inhibitors; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Male; Neuroprotective Agents; Olanzapine; Phenylcarbamates; Pirenzepine; Risperidone; Rivastigmine; Treatment Outcome

2003
Dementia with Lewy bodies presenting marked tongue protrusion and bite due to lingual dystonia: A case report.
    Rinsho shinkeigaku = Clinical neurology, 2016, 06-22, Volume: 56, Issue:6

    Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bites and Stings; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Indoles; Laryngeal Diseases; Levodopa; Lewy Body Disease; Middle Aged; Olanzapine; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiophenes; Tongue Diseases

2016